Elizabeth Garofalo, M.D.

Elizabeth Garofalo, M.D.

DirectoratXenon Pharmaceuticals· In proxies 2023–2025

Elizabeth Garofalo, M.D. sits on 6 public boards.

Boards1

  • AlectorDirector · 4 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Xenon PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -4%
  2. AlectorPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Acadia Pharmaceuticals Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Acadia Pharmaceuticals Inc., andPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  5. Alector, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Exicure, Inc.Public company · 1 yr
    • Director2022 – 2023 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?